Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits ResearchGlobeNewsWire • 07/16/24
DaVita HealthCare (DVA) Surpasses Market Returns: Some Facts Worth KnowingZacks Investment Research • 07/09/24
These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?The Motley Fool • 06/07/24
DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care ReportPRNewsWire • 05/14/24
DaVita HealthCare (DVA) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 05/06/24